Robert G. Weiss, M.D. Professor of Medicine, Division of Cardiology Professor of Radiology
Director, Donald W. Reynolds Cardiovascular Clinical Research Center Director, Project 2
rweiss@jhmi.edu | 
|
| Dr. Robert G. Weiss is on the forefront of developing and implementing imaging technology that is helping clinicians to better understand cardiovascular disease and correctly diagnose its presence in people. Dr. Weiss is Professor of Medicine in the Division of Cardiology, Professor of Radiology, and Director of Cardiac MR Spectroscopy. As Principal Investigator for Project 2 in the Donald W. Reynolds Cardiovascular Clinical Research Center, he is leading efforts to develop new, non-invasive imaging and spectroscopic techniques to identify individuals at greatest risk for sudden cardiac death. With a broad spectrum of clinical and basic research interests in cardiovascular medicine and imaging, Dr. Weiss has a strong track record of innovation and leadership at Johns Hopkins University. His recent publications include: - Naumova AV, Weiss RG, Chacko VP. Regulation of murine myocardial energy metabolism during adrenergic stress studied by in vivo 31P NMR spectroscopy. Am J Physiol Heart Circ Physiol 2003; 285(5): H1976-9.
- Bottomley PA, Ouwerkerk R, Lee RF, Weiss RG. Four-angle saturation transfer (FAST) method for measuring creatine kinase reaction rates in vivo. Magn Reson Imaging 2002; 47(5): 850-63.
- Weiss RG, et al. An increase in the myocardial PCr/ATP ratio in GLUT4 null mice. FASEB 2002; 16(6): 613-5.
- Bottomley PA, Weiss RG. Noninvasive localized MR quantification of creatine kinase metabolites in normal and infracted canine myocardium. Radiology 2001; 219(2): 411-8.
- Weiss RG, Mejia MA, Chacko VP, DiPaula AF, Becker LC, Kass DA, Gerstenblith G,: Preservation of canine myocardial high-energy phosphates during low-flow ischemia with synthetic allosteric modification of hemoglobin-oxygen affinity. The Journal of Clinical Investigation 103:739-746, 1999.
- Bottomley PA and Weiss RG: Creatine depletion in non-viable, infarcted myocardium measured by noninvasive MRS. The Lancet 351:714-718; 1998.
|